Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 25(2): 184-7, 2015 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-25499434

RESUMO

(-)-Cryptopleurine 1 is one of the most potent anti-proliferative member of the phenanthroquinolizidine class of alkaloids. We report here the synthesis of (-)-6-O-desmethylcryptopleurine (-)-2 and (-)-6-O-desmethyl-(15R)-hydroxycryptopleurine (-)-4 in their enantiomerically enriched form through a convergent synthetic route, where the chirality is introduced by the use of commercially available (R)-methyl piperidine-2-carboxylate hydrochloride 17. Anti-proliferative activities of these compounds were evaluated on a panel of four cancer cell lines, revealing that compounds (-)-2 and (-)-4 are potent cytotoxic compared to cryptopleurine.


Assuntos
Alcaloides/síntese química , Alcaloides/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/fisiologia , Avaliação Pré-Clínica de Medicamentos/métodos , Humanos
2.
Bioorg Med Chem Lett ; 25(10): 2078-81, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25872984

RESUMO

Griseofulvin, an antifungal drug, has been shown in recent years to have anti-proliferative activities. We report here the synthesis of new analogs of griseofulvin, substituted in 2' by a sulfonyl group or in 3' by a sulfinyl or sulfonyl group. These compounds exhibit good anti-proliferative activities against SCC114 cells, an oral squamous carcinoma cell line showing pronounced centrosome amplification, and unexpected cytotoxic activities on HCC1937 cells, a triple negative breast cancer cell line resistant to microtubule inhibitors.


Assuntos
Griseofulvina/síntese química , Griseofulvina/farmacologia , Neoplasias/patologia , Sulfonas/química , Sulfóxidos/química , Linhagem Celular Tumoral , Resistencia a Medicamentos Antineoplásicos , Griseofulvina/química , Humanos
3.
JCI Insight ; 4(21)2019 11 01.
Artigo em Inglês | MEDLINE | ID: mdl-31672935

RESUMO

Pancreatic ductal adenocarcinoma (PDAC) relies on hyperactivated protein synthesis. Consistently, human and mouse PDAC lose expression of the translational repressor and mTOR target 4E-BP1. Using genome-wide polysome profiling, we here explore mRNAs whose translational efficiencies depend on the mTOR/4E-BP1 axis in pancreatic cancer cells. We identified a functional enrichment for mRNAs encoding DNA replication and repair proteins, including RRM2 and CDC6. Consequently, 4E-BP1 depletion favors DNA repair and renders DNA replication insensitive to mTOR inhibitors, in correlation with a sustained protein expression of CDC6 and RRM2, which is inversely correlated with 4E-BP1 expression in PDAC patient samples. DNA damage and pancreatic lesions induced by an experimental pancreatitis model uncover that 4E-BP1/2-deleted mice display an increased acinar cell proliferation and a better recovery than WT animals. Targeting translation, independently of 4E-BP1 status, using eIF4A RNA helicase inhibitors (silvestrol derivatives) selectively modulates translation and limits CDC6 expression and DNA replication, leading to reduced PDAC tumor growth. In summary, 4E-BP1 expression loss during PDAC development induces selective changes in translation of mRNA encoding DNA replication and repair protein. Importantly, targeting protein synthesis by eIF4A inhibitors circumvents PDAC resistance to mTOR inhibition.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/genética , Carcinoma Ductal Pancreático/metabolismo , Proteínas de Ciclo Celular/genética , Replicação do DNA , Fator de Iniciação 4A em Eucariotos/antagonistas & inibidores , Neoplasias Pancreáticas/metabolismo , Animais , Carcinoma Ductal Pancreático/genética , Carcinoma Ductal Pancreático/patologia , Linhagem Celular Tumoral , Humanos , Camundongos , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/patologia , Biossíntese de Proteínas , Serina-Treonina Quinases TOR/antagonistas & inibidores
4.
Org Lett ; 8(2): 321-4, 2006 Jan 19.
Artigo em Inglês | MEDLINE | ID: mdl-16408905

RESUMO

[structure: see text] Liphagal (1), a selective inhibitor of PI3K alpha, has been isolated from the marine sponge Aka coralliphaga collected in Dominica. The "liphagane" meroterpenoid carbon skeleton of liphagal (1) is new. A biomimetic total synthesis has been used to confirm the constitution of liphagal (1) and support a proposed biogenesis.


Assuntos
Inibidores de Fosfoinositídeo-3 Quinase , Poríferos/química , Terpenos/síntese química , Androstadienos/farmacologia , Animais , Cromonas/farmacologia , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Estrutura Molecular , Morfolinas/farmacologia , Terpenos/isolamento & purificação , Terpenos/farmacologia , Células Tumorais Cultivadas , Wortmanina
5.
Org Lett ; 5(26): 5095-7, 2003 Dec 25.
Artigo em Inglês | MEDLINE | ID: mdl-14682773

RESUMO

A radical cascade involving a 5-exo-dig cyclization followed by a 6-endo-trig radical trapping transforms ynamides into heterogeneous polycyclic compounds in good yields. This leads interestingly to the formation of isoindols, isoindolinones, and pyridoisoindolones. [reaction: see text]

6.
Org Lett ; 6(9): 1509-11, 2004 Apr 29.
Artigo em Inglês | MEDLINE | ID: mdl-15101779

RESUMO

[reaction: see text] Various ene-tosylynamides react with platinum(II) chloride and lead to bicyclic nitrogenated heterocycles. This unprecedented and easily operated process can be coupled with a hydrolysis of the intermediate cyclic tosylenamides in a one-pot transformation, which provides cyclobutanones.

7.
J Med Chem ; 53(24): 8523-33, 2010 Dec 23.
Artigo em Inglês | MEDLINE | ID: mdl-21121631

RESUMO

Analogues of the sponge meroterpenoid liphagal have been synthesized and evaluated for inhibition of PI3Kα and PI3Kγ as part of a program aimed at developing new isoform-selective PI3K inhibitors. One of the analogues, compound 24, with IC50 values of 66 nM against PI3Kα and 1840 nM against PI3Kγ, representing a 27-fold preference for PI3Kα, exhibited enhanced chemical stability and modestly enhanced potency and selectivity compared with the natural product liphagal.


Assuntos
Inibidores de Fosfoinositídeo-3 Quinase , Poríferos , Terpenos/síntese química , Animais , Estabilidade de Medicamentos , Humanos , Isoenzimas/antagonistas & inibidores , Isoenzimas/química , Fosfatidilinositol 3-Quinase/química , Estereoisomerismo , Relação Estrutura-Atividade , Terpenos/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA